Cactus Clinical Research

Executive Summary

Cactus Clinical Research is a private Site Management Organization (SMO) headquartered in Princeton, NJ, with clinical research sites in Phoenix, Arizona. Founded in 2012, the company partners with pharmaceutical sponsors to conduct Phase II through Phase IV clinical trials across therapeutic areas including Internal Medicine, Gynecology, Urogynecology, and Women's Health. By providing patients with access to investigational treatments and study-related care at no cost, Cactus plays a vital role in advancing medical research while serving a growing patient population in the Southwest U.S. As a specialized SMO, Cactus Clinical Research is well-positioned to benefit from the increasing outsourcing of clinical trial management by biopharma companies. The company’s focus on high-demand therapeutic areas and its established presence in Phoenix—a region with a diverse and growing demographic—support its growth trajectory. While financial details remain private, the company’s operating history since 2012 suggests operational stability. Key drivers for future growth include expanding its site network, forging new strategic partnerships, and capitalizing on the post-pandemic rebound in clinical trial activity. However, competition from larger SMOs and CROs and the capital-intensive nature of site expansion present ongoing challenges.

Upcoming Catalysts (preview)

• Q3 2026New Multi-Year Partnership with Top Pharma Sponsor50% success
• Q4 2026Expansion to Additional Clinical Sites in Southwest U.S.40% success
• Q2 2026Completion of Enrollment for Major Phase III Trial in Women's Health30% success